Methocarbamol
Methocarbamol Tablets USP
Approved
Approval ID
d8f10211-f96e-4cf3-9b49-986eb51b703d
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 13, 2022
Manufacturers
FDA
AustarPharma LLC
DUNS: 362785011
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Methocarbamol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code35561-211
Application NumberANDA200958
Product Classification
M
Marketing Category
C73584
G
Generic Name
Methocarbamol
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 13, 2022
FDA Product Classification
INGREDIENTS (1)
METHOCARBAMOLActive
Quantity: 750 mg in 1 1
Code: 125OD7737X
Classification: ACTIB
Methocarbamol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code35561-212
Application NumberANDA200958
Product Classification
M
Marketing Category
C73584
G
Generic Name
Methocarbamol
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 13, 2022
FDA Product Classification
INGREDIENTS (1)
METHOCARBAMOLActive
Quantity: 500 mg in 1 1
Code: 125OD7737X
Classification: ACTIB